Alexandra Papaioannou

Author PubWeight™ 102.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007 4.68
2 Trends in hip fracture rates in Canada. JAMA 2009 2.95
3 Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 2009 2.64
4 A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002 2.16
5 Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int 2004 2.09
6 A systematic review and meta-analysis of studies using the STRATIFY tool for prediction of falls in hospital patients: how well does it work? Age Ageing 2008 1.94
7 Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ 2006 1.74
8 Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician 2014 1.63
9 Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev 2013 1.63
10 References to anesthesia, pain, and analgesia in the Hippocratic Collection. Anesth Analg 2009 1.48
11 The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord 2002 1.47
12 Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 2002 1.44
13 Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey. J Obstet Gynaecol Can 2004 1.38
14 Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Fam Pract 2006 1.36
15 Emergency Department and Walk-in Clinic Use in Models of Primary Care Practice with Different After-Hours Accessibility in Ontario. Healthc Policy 2008 1.36
16 Canadian Consensus Conference on osteoporosis, 2006 update. J Obstet Gynaecol Can 2006 1.33
17 Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 2005 1.31
18 Management of osteoporosis in men: an update and case example. CMAJ 2007 1.29
19 Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res 2007 1.28
20 Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord 2005 1.27
21 Bone strength: the whole is greater than the sum of its parts. Semin Arthritis Rheum 2006 1.18
22 Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord 2008 1.16
23 Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res 2009 1.15
24 Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J 2011 1.11
25 Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis. J Clin Epidemiol 2006 1.09
26 Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician 2008 1.08
27 Pain management decision making among long-term care physicians and nurses. West J Nurs Res 2007 1.07
28 Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review. Drug Saf 2002 1.06
29 Retracted Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis 2009 1.05
30 Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review. BMC Geriatr 2008 1.03
31 The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004 1.01
32 Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr 2009 1.01
33 The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord 2011 0.99
34 Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab 2013 0.99
35 An interdisciplinary knowledge translation intervention in long-term care: study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial. Implement Sci 2012 0.98
36 Depressive symptomatology and fracture risk in community-dwelling older men and women. Aging Clin Exp Res 2008 0.97
37 A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents. PLoS One 2010 0.95
38 The burden of osteoporotic fractures beyond acute care: the Canadian Multicentre Osteoporosis Study (CaMos). Age Ageing 2011 0.94
39 Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab 2013 0.93
40 Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls. Arthritis Care Res (Hoboken) 2012 0.93
41 Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. BMC Musculoskelet Disord 2002 0.92
42 Nurses' perceived barriers to optimal pain management in older adults on acute medical units. Appl Nurs Res 2009 0.92
43 Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskelet Disord 2005 0.91
44 What is the number of older Canadians needed to screen by measurement of bone density to detect an undiagnosed case of osteoporosis? a population-based study from CaMos. J Clin Densitom 2006 0.90
45 Prevalence of osteoporosis in osteoarthritic patients undergoing total hip or total knee arthroplasty. Arch Phys Med Rehabil 2008 0.90
46 Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. BMC Musculoskelet Disord 2010 0.90
47 Fracture risk assessment in long-term care: a survey of long-term care physicians. BMC Geriatr 2013 0.89
48 Measurement of cervical flexor endurance following whiplash. Disabil Rehabil 2005 0.89
49 The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC). BMC Med Educ 2009 0.89
50 Assessing adherence to teriparatide therapy, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture. Ther Adv Musculoskelet Dis 2009 0.88
51 Hip fracture prevention strategies in long-term care: a survey of Canadian physicians' opinions. Can Fam Physician 2010 0.87
52 Improvement in health-related quality of life in osteoporosis patients treated with teriparatide. BMC Musculoskelet Disord 2008 0.85
53 What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention? BMC Geriatr 2010 0.85
54 Frailty index of deficit accumulation and falls: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort. BMC Musculoskelet Disord 2014 0.84
55 Trends in hip fracture rates in Canada: an age-period-cohort analysis. J Bone Miner Res 2013 0.84
56 Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents. J Anesth 2011 0.84
57 Brain type carnosinase in dementia: a pilot study. BMC Neurol 2007 0.83
58 Optimizing care in osteoporosis: the Canadian quality circle project. BMC Musculoskelet Disord 2008 0.83
59 The burden of illness of osteoporosis in Canadian men. J Bone Miner Res 2012 0.82
60 Validation of the GALS musculoskeletal screening exam for use in primary care: a pilot study. BMC Musculoskelet Disord 2008 0.82
61 What predicts early fracture or bone loss on bisphosphonate therapy? J Clin Densitom 2003 0.82
62 The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future. Semin Arthritis Rheum 2006 0.82
63 Reproducibility of peripheral quantitative computed tomography measurements at the radius and tibia in healthy pre- and postmenopausal women. Can Assoc Radiol J 2010 0.81
64 Pain management practices with older adults on acute medical units. Perspectives 2008 0.81
65 Case report: osteogenesis imperfecta Elusive cause of fractures. Can Fam Physician 2005 0.81
66 Canadian Quality Circle pilot project in osteoporosis: rationale, methods, and feasibility. Can Fam Physician 2007 0.81
67 Association between vitamin D3 supplementation and serum 25-hydroxyvitamin D levels in older individuals residing in long-term care in Ontario, Canada. J Am Geriatr Soc 2012 0.81
68 The evaluation of an interdisciplinary pain protocol in long term care. J Am Med Dir Assoc 2012 0.80
69 Piloting a renal drug alert system for prescribing to residents in long-term care. J Am Geriatr Soc 2011 0.80
70 Vertebral compression fractures in primary care: recommendations from a consensus panel. J Fam Pract 2005 0.79
71 Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis. CMAJ 2006 0.79
72 The use of hip protectors in long-term care facilities: a survey of nursing home staff. J Am Med Dir Assoc 2007 0.79
73 A systematic review of the effect of alendronate on bone mineral density in men. J Clin Densitom 2005 0.79
74 Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol. Syst Rev 2013 0.79
75 Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices? J Rheumatol 2004 0.78
76 Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporos 2014 0.78
77 A 6-mo home-based exercise program may slow vertebral height loss. J Clin Densitom 2003 0.78
78 The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer. J Oncol 2012 0.78
79 Estimating osteoporotic fracture risk following a wrist fracture: a tale of two systems. Arch Osteoporos 2015 0.77
80 Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study. BMC Musculoskelet Disord 2013 0.77
81 Bone-density testing interval and transition to osteoporosis. N Engl J Med 2012 0.77
82 Rational use of oral bisphosphonates for the treatment of osteoporosis. Curr Osteoporos Rep 2004 0.77
83 Impact of a mandatory geriatric medicine clerkship on the care of older acute medical patients: a retrospective cohort study. BMC Med Educ 2013 0.77
84 Normative bone mineral density z-scores for Canadians aged 16 to 24 years: the Canadian Multicenter Osteoporosis Study. J Clin Densitom 2010 0.77
85 Body weight-supported treadmill training for patients with hip fracture: a feasibility study. Arch Phys Med Rehabil 2009 0.77
86 Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study. BMC Musculoskelet Disord 2014 0.77
87 Family physicians' personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing. Popul Health Manag 2009 0.77
88 Treating osteoporosis: economic aspects of bisphosphonate therapy. Expert Opin Pharmacother 2006 0.77
89 Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk. Menopause 2010 0.77
90 Osteoporosis in Canadian adult cystic fibrosis patients: a descriptive study. BMC Musculoskelet Disord 2003 0.77
91 The relationship between long-term proton pump inhibitor therapy and skeletal frailty. Endocrine 2015 0.77
92 Nurses' perceptions of and satisfaction with the medication administration system in long-term-care homes. Can J Nurs Res 2010 0.76
93 Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis? J Obstet Gynaecol Can 2005 0.76
94 An action-based approach to improving pain management in long-term care. Can J Aging 2010 0.76
95 In whom and how to prevent glucocorticoid-induced osteoporosis. Best Pract Res Clin Rheumatol 2005 0.76
96 Feasibility study of walking for exercise in individuals living in assisted living settings. J Geriatr Phys Ther 2013 0.75
97 Clinical risk factors for fracture in diabetes: a matched cohort analysis. J Clin Densitom 2011 0.75
98 Data sharing between home care professionals: a feasibility study using the RAI Home Care instrument. BMC Geriatr 2014 0.75
99 Managing pain medications in long-term care: nurses' views. Br J Nurs 2015 0.75
100 Renal impairment and medication use among psychogeriatric inpatients. Can J Clin Pharmacol 2003 0.75
101 Glucocorticoid-induced osteoporosis. Womens Health (Lond Engl) 2006 0.75
102 An amantadine hydrochloride dosing program adjusted for renal function during an influenza outbreak in elderly institutionalized patients. Can J Clin Pharmacol 2003 0.75
103 Emergencies and acute diseases in the collected works of Hippocrates: observation, examination, prognosis, therapy. Eur J Emerg Med 2016 0.75
104 Exploring Fear of Falling and Exercise Self-Efficacy in Older Women With Vertebral Fractures. J Aging Phys Act 2020 0.75